The Poliovirus Replication Machinery Can Escape Inhibition by an Antiviral Drug That Targets a Host Cell Protein

Journal of Virology

Volumn 78, Issue 7, 2004, Pages 3378-3386

  Crotty, Shane ^a,c   Saleh, Maria Carla ^a   Gitlin, Leonid ^a   Beske, Oren ^a   Andino, Raul ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BREFELDIN A; PROTEIN 2C; PROTEIN 3A; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; 2C PROTEIN, VIRAL; 3A PROTEIN, POLIOVIRUS; CARRIER PROTEIN; CORE PROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; HUMAN CELL; MEMBRANE VESICLE; PHENOTYPE; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN TARGETING; RNA REPLICATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; ANTIBIOTIC RESISTANCE; CELL LINE; CYTOPLASM VESICLE; DRUG EFFECT; GENETICS; GOLGI COMPLEX; HELA CELL; HOST PARASITE INTERACTION; INTRACELLULAR MEMBRANE; KINETICS; METABOLISM; PHYSIOLOGY; REPLICON;

ANTIVIRAL AGENTS; BREFELDIN A; CARRIER PROTEINS; CELL LINE; CYTOPLASMIC VESICLES; DRUG RESISTANCE, VIRAL; GOLGI APPARATUS; HELA CELLS; HOST-PARASITE RELATIONS; HUMANS; INTRACELLULAR MEMBRANES; KINETICS; PHENOTYPE; POLIOVIRUS; REPLICON; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 1842562401     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.7.3378-3386.2004     Document Type: Article

References (50)

1. Andino, R., G. E. Rieckhof, P. L. Achacoso, and D. Baltimore. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′ end of viral RNA. EMBO J. 12:3587-3598.
2. Beneduce, F., G. Pisani, M. Divizia, A. Pana, and G. Morace. 1995. Complete nucleotide sequence of a cytopathic hepatitis A virus strain isolated in Italy. Virus Res. 36:299-309.
3. Bienz, K., D. Egger, and L. Pasamontes. 1987. Association of polioviral proteins of the P2 genomic region with the viral replication complex and virus-induced membrane synthesis as visualized by electron microscopic immunocytochemistry and autoradiography. Virology 160:220-226.
4. Bienz, K., D. Egger, T. Pfister, and M. Troxler. 1992. Structural and functional characterization of the poliovirus replication complex. J. Virol. 66:2740-2747.
5. Bienz, K., D. Egger, Y. Rasser, and W. Bossart. 1983. Intracellular distribution of poliovirus proteins and the induction of virus-specific cytoplasmic structures. Virology 131:39-48.
6. Bienz, K., D. Egger, M. Troxler, and L. Pasamontes. 1990. Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. J. Virol. 64:1156-1163.
7. Blair, E. 1998. Antiviral therapy. Springer, New York, N.Y.
8. Bolten, R., D. Egger, R. Gosert, G. Schaub, L. Landmann, and K. Bienz. 1998. Intracellular localization of poliovirus plus- and minus-strand RNA visualized by strand-specific fluorescent in situ hybridization. J. Virol. 72:8578-8585.
9. Chardin, P., and F. McCormick. 1999. Brefeldin A: the advantage of being uncompetitive. Cell 97:153-155.
10. Cho, M. W., N. Teterina, D. Egger, K. Bienz, and E. Ehrenfeld. 1994. Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology 202:129-145.
11. Crotty, S., C. E. Cameron, and R. Andino. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 98:6895-6900.
12. Crotty, S., B. L. Lohman, F. X. Lu, S. Tang, C. J. Miller, and R. Andino. 1999. Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal, and cellular immunity. J. Virol. 73:9485-9495.
13. Crotty, S., D. Maag, J. J. Arnold, W. Zhong, J. Y. Lau, Z. Hong, R. Andino, and C. E. Cameron. 2000. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 6:1375-1379.
14. Cuconati, A., A. Molla, and E. Wimmer. 1998. Brefeldin A inhibits cell-free, de novo synthesis of poliovirus. J. Virol. 72:6456-6464.
15. Deitz, S. B., D. A. Dodd, S. Cooper, P. Parham, and K. Kirkegaard. 2000. MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc. Natl. Acad. Sci. USA 97:13790-13795.
16. Doedens, J., L. A. Maynell, M. W. Klymkowsky, and K. Kirkegaard. 1994. Secretory pathway function, but not cytoskeletal integrity, is required in poliovirus infection. Arch. Virol. Suppl. 9:159-172.
17. Doedens, J. R., T. H. Giddings, Jr., and K. Kirkegaard. 1997. Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis. J. Virol. 71:9054-9064.
18. Domingo, E., J. J. Holland, and P. Ahlquist. 1988. RNA genetics. CRC Press, Inc., Boca Raton, Fla.
19. Echeverri, A. C., and A. Dasgupta. 1995. Amino-terminal regions of poliovirus 2C protein mediate membrane binding. Virology 208:540-553.
20. Egger, D., R. Gosert, and K. Bienz. 2002. Role of cellular structures in viral RNA replication, p. 247-254. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, D.C.
21. Egger, D., L. Pasamontes, R. Bolten, V. Boyko, and K. Bienz. 1996. Reversible dissociation of the poliovirus replication complex: functions and interactions of its components in viral RNA synthesis. J. Virol. 70:8675-8683.
22. Egger, D., N. Teterina, E. Ehrenfeld, and K. Bienz. 2000. Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J. Virol. 74:6570-6580.
23. Galasso, G. J., R. J. Whitley, and T. C. Merigan. 1997. Antiviral agents and human viral diseases, 4th ed. Lippincott-Raven Publishers, Philadelphia, Pa.
24. pol): structural, biochemical, and biological analysis of conserved structural motifs A and B. J. Biol. Chem. 275:25523-25532.
25. Gorbalenya, A. E., E. V. Koonin, and Y. I. Wolf. 1990. A new superfamily of putative NTP-binding domains encoded by genomes of small DNA and RNA viruses. FEBS Lett. 262:145-148.
26. Graff, J., C. Kasang, A. Normann, M. Pfisterer-Hunt, S. M. Feinstone, and B. Flehmig. 1994. Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptation. Virology 204:60-68.
27. Harris, J. R., and V. R. Racaniello. 2003. Changes in rhinovirus protein 2C allow efficient replication in mouse cells. J. Virol. 77:4773-4780.
28. Herold, J., and R. Andino. 2000. Poliovirus requires a precise 5′ end for efficient positive-strand RNA synthesis. J. Virol. 74:6394-6400.
29. Irurzun, A., L. Perez, and L. Carrasco. 1992. Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A. Virology 191:166-175.
30. Jeffries, D. J., and E. DeClercq. 1995. Antiviral chemotherapy. Wiley, Chichester, England.
31. Klausner, R. D., J. G. Donaldson, and J. Lippincott-Schwartz. 1992. Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 116:1071-1080.
32. Lama, J., M. A. Sanz, and L. Carrasco. 1998. Genetic analysis of poliovirus protein 3A: characterization of a non-cytopathic mutant virus defective in killing Vero cells. J. Gen. Virol. 79:1911-1921.
33. Maynell, L. A., K. Kirkegaard, and M. W. Klymkowsky. 1992. Inhibition of poliovirus RNA synthesis by brefeldin A. J. Virol. 66:1985-1994.
34. Meijer, L., S. Leclerc, and M. Leost. 1999. Properties and potential: applications of chemical inhibitors of cyclin-dependent kinases. Pharmacol. Ther. 82:279-284.
35. Morace, G., G. Pisani, F. Beneduce, M. Divizia, and A. Pana. 1993. Mutations in the 3A genomic region of two cytopathic strains of hepatitis A virus isolated in Italy. Virus Res. 28:187-194.
36. Morse, S. S. 1994. The evolutionary biology of viruses. Raven Press, New York, N.Y.
37. Peyroche, A., B. Antonny, S. Robineau, J. Acker, J. Cherfils, and C. L. Jackson. 1999. Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex: involvement of specific residues of the Sec7 domain. Mol. Cell 3:275-285.
38. Pfister, T., K. W. Jones, and E. Wimmer. 2000. A cysteine-rich motif in poliovirus protein 2C(ATPase) is involved in RNA replication and binds zinc in vitro. J. Virol. 74:334-343.
39. Pfister, T., and E. Wimmer. 1999. Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J. Biol. Chem. 274:6992-7001.
40. Racaniello, V. R., and D. Baltimore. 1981. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science 214:916-919.
41. Rodriguez, P. L., and L. Carrasco. 1995. Poliovirus protein 2C contains two regions involved in RNA-binding activity. J. Biol. Chem. 270:10105-10112.
42. Rust, R. C., L. Landmann, R. Gosert, B. L. Tang, W. Hong, H. P. Hauri, D. Egger, and K. Bienz. 2001. Cellular COPII proteins are involved in production of the vesicles that form the poliovirus replication complex. J. Virol. 75:9808-9818.
43. Sandoval, I. V., and L. Carrasco. 1997. Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J. Virol. 71:4679-4693.
44. Schang, L. M., A. Rosenberg, and P. A. Schaffer. 2000. Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins. J. Virol. 74:2107-2120.
45. Schlegel, A., T. H. Giddings, Jr., M. S. Ladinsky, and K. Kirkegaard. 1996. Cellular origin and ultrastructure of membranes induced during poliovirus infection. J. Virol. 70:6576-6588.
46. Schlegel, A., and K. Kirkegaard. 1995. Cell biology of enterovirus infection, p. 135-154. In H. Rotbart (ed.), Human enterovirus infections. ASM Press, Washington, D.C.
47. Suhy, D. A., T. H. Giddings, Jr., and K. Kirkegaard. 2000. Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J. Virol. 74:8953-8965.
48. Tang, S., R. van Rij, D. Silvera, and R. Andino. 1997. Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity. J. Virol. 71:7841-7850.
49. Tershak, D. R. 1984. Association of poliovirus proteins with the endoplasmic reticulum. J. Virol. 52:777-783.
50. Towner, J., and B. L. Semler. 1996. Determinants of membrane association on poliovirus protein 3AB. J. Biol. Chem. 271:26810-26818.